MDxHealth SA
MDXH3.530USD
+0.130+3.82%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
174.73M시가총액
손실P/E TTM
자세한 내용은 MDxHealth SA 회사
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
MDxHealth SA 정보
종목 코드 MDXH
회사 이름MDxHealth SA
상장일Jun 26, 2006
CEOMr. Michael K. McGarrity
직원 수312
유형Ordinary Share
회계 연도 종료Jun 26
주소CAP Business Center
도시HERSTAL
증권 거래소NASDAQ Capital Market Consolidated
국가Belgium
우편 번호4040
전화3243642070
웹사이트https://mdxhealth.com/
종목 코드 MDXH
상장일Jun 26, 2006
CEOMr. Michael K. McGarrity
MDxHealth SA의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Michael K. McGarrity
Mr. Michael K. McGarrity
Chief Executive Officer, Director
Chief Executive Officer, Director
95.00K
--
Mr. Michael Holder
Mr. Michael Holder
Director
Director
--
--
Mr. Mark Shaffar
Mr. Mark Shaffar
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Christopher (Chris) Thibodeau
Mr. Christopher (Chris) Thibodeau
Executive Vice President & U.S. Chief Operations Officer
Executive Vice President & U.S. Chief Operations Officer
--
--
Dr. Sanford S Siegel, M.D.
Dr. Sanford S Siegel, M.D.
Director
Director
--
--
Mr. Joseph (Joe) Sollee
Mr. Joseph (Joe) Sollee
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mr. John Bellano
Mr. John Bellano
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Rudi Marien
Mr. Rudi Marien
Non-Executive Director
Non-Executive Director
--
--
Mme. Ruth Devenyns
Mme. Ruth Devenyns
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Walter M. (Wally) Narajowski
Mr. Walter M. (Wally) Narajowski
Non-Executive Independent Director
Non-Executive Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Michael K. McGarrity
Mr. Michael K. McGarrity
Chief Executive Officer, Director
Chief Executive Officer, Director
95.00K
--
Mr. Michael Holder
Mr. Michael Holder
Director
Director
--
--
Mr. Mark Shaffar
Mr. Mark Shaffar
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Christopher (Chris) Thibodeau
Mr. Christopher (Chris) Thibodeau
Executive Vice President & U.S. Chief Operations Officer
Executive Vice President & U.S. Chief Operations Officer
--
--
Dr. Sanford S Siegel, M.D.
Dr. Sanford S Siegel, M.D.
Director
Director
--
--
Mr. Joseph (Joe) Sollee
Mr. Joseph (Joe) Sollee
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2023
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States of America
69.71M
99.31%
Europe
476.00K
0.68%
Rest of the world
9.00K
0.01%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sat, Feb 7
마지막 업데이트: Sat, Feb 7
주주
주주 유형
주주
주주
비율
Bleichroeder LP
14.91%
AWM Investment Company, Inc.
10.55%
MVM Partners LLP
9.50%
Lytton (Laurence W)
6.36%
Genomic Health, Inc.
4.93%
기타
53.75%
주주
주주
비율
Bleichroeder LP
14.91%
AWM Investment Company, Inc.
10.55%
MVM Partners LLP
9.50%
Lytton (Laurence W)
6.36%
Genomic Health, Inc.
4.93%
기타
53.75%
주주 유형
주주
비율
Investment Advisor
20.60%
Investment Advisor/Hedge Fund
14.94%
Venture Capital
9.52%
Individual Investor
6.67%
Corporation
4.93%
Hedge Fund
1.21%
Research Firm
0.12%
기타
42.00%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
71
22.89M
46.25%
-1.34M
2025Q3
49
21.80M
44.04%
-2.18M
2025Q2
45
28.07M
56.71%
+2.44K
2025Q1
47
29.82M
60.25%
-710.83K
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Bleichroeder LP
7.38M
14.91%
--
--
Sep 30, 2025
AWM Investment Company, Inc.
5.22M
10.55%
--
--
Sep 30, 2025
MVM Partners LLP
4.70M
9.5%
--
--
Sep 30, 2025
Lytton (Laurence W)
3.15M
6.36%
-799.84K
-20.25%
Sep 30, 2025
Genomic Health, Inc.
2.44M
4.93%
+1.50M
+159.38%
Sep 27, 2024
Samjo Capital, LLC
1.45M
2.92%
-89.90K
-5.86%
Sep 30, 2025
Perkins Capital Management, Inc.
1.40M
2.83%
-17.42K
-1.23%
Sep 30, 2025
Kennedy Capital Management LLC
392.65K
0.79%
+344.85K
+721.41%
Sep 30, 2025
Northern Trust Global Investments Limited
305.07K
0.62%
-106.86K
-25.94%
Sep 30, 2025
FreeGulliver LLC
252.89K
0.51%
+129.35K
+104.70%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0.04%
iShares Micro-Cap ETF
비율0.04%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
